Basics Oric Pharmaceuticals, Inc. IPO Date: April 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $410.89M Activated in VL: True Average Daily Range Avg Daily Range: $0.48 | 3.70% Avg Daily Range (30 D): $0.28 | 5.02% Avg Daily Range (90 D): $0.34 | 4.81% Institutional Daily Volume Avg Daily Volume: .35M Avg Daily Volume (30 D): 1.07M Avg Daily Volume (90 D): .99M Trade Size Avg Trade Size (Sh.): 87 Avg Trade Size (Sh.) (30 D): 97 Avg Trade Size (Sh.) (90 D): 94 Institutional Trades Total Inst.Trades: 702 Avg Inst. Trade: $1.47M Avg Inst. Trade (30 D): $1.19M Avg Inst. Trade (90 D): $.91M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.76M Avg Closing Trade (30 D): $1.38M Avg Closing Trade (90 D): $1.01M Avg Closing Volume: 142.76K         News Feb 7, 2025 @ 9:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc. Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Jan 3, 2025 @ 9:30 PM ORIC Pharmaceuticals Reports Inducement Grants ... Source: Oric Pharmaceuticals, Inc. Nov 20, 2024 @ 12:00 PM C4 Therapeutics Appoints Accomplished Oncology Exe... Source: N/A Oct 4, 2024 @ 8:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.42 $-.51 $-1.83 Diluted EPS $-.42 $-.51 $-1.83 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -30.02M $ -36.31M $ -127.85M Operating Income / Loss $ -32.72M $ -39.57M $ -142.9M Cost of Revenue $ $ $ Net Cash Flow $ -10.07M $ 15.18M $ 36.02M PE Ratio